MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.625207
Abstract: A wide range of malignancies presents MYCN amplification (MNA) or dysregulation. MYCN is associated with poor prognosis and its over-expression leads to several dysregulations including metabolic reprogramming, mitochondria alteration, and cancer stem cell phenotype. Some… read more here.
Keywords: mna; drives tumor; mycn drives; mycn ... See more keywords